TMB-H

Clinical trials for TMB-H explained in plain language.

Never miss a new study

Get alerted when new TMB-H trials appear

Sign up with your email to follow new studies for TMB-H, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug IMC-001 targets Hard-to-Treat cancers in small trial

Disease control Recruiting now

This phase 2 trial tests the drug IMC-001 in 30 adults with advanced solid tumors that have a high number of genetic mutations (TMB-H). Participants receive the drug by IV every two weeks. The main goal is to see if the drug shrinks tumors. Researchers will also monitor side effe…

Matched conditions: TMB-H

Phase: PHASE2 • Sponsor: ImmuneOncia Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

TMB-H

Get alerted when new TMB-H trials appear

New drug IMC-001 targets Hard-to-Treat cancers in small trial